TRENTAL Trademark

Trademark Overview

On Wednesday, June 2, 2021, a trademark application was filed for TRENTAL with the United States Patent and Trademark Office. The USPTO has given the TRENTAL trademark a serial number of 90750113. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, March 25, 2024. This trademark is owned by Validus Pharmaceuticals LLC. The TRENTAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of arterial and arteriovenous circulatory disorders
trental

General Information

Serial Number90750113
Word MarkTRENTAL
Filing DateWednesday, June 2, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, March 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 15, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of arterial and arteriovenous circulatory disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 25, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameValidus Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054
Party NameValidus Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Saturday, June 5, 2021NEW APPLICATION ENTERED
Wednesday, August 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 3, 2022ASSIGNED TO EXAMINER
Monday, February 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 15, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 10, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 26, 2022SOU TEAS EXTENSION RECEIVED
Monday, September 26, 2022SOU EXTENSION 1 FILED
Monday, September 26, 2022SOU EXTENSION 1 GRANTED
Wednesday, September 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 4, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 4, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 4, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 12, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, April 12, 2023SOU EXTENSION 2 FILED
Wednesday, April 12, 2023SOU EXTENSION 2 GRANTED
Friday, April 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 27, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 27, 2023SOU EXTENSION 3 FILED
Wednesday, September 27, 2023SOU EXTENSION 3 GRANTED
Friday, September 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 25, 2024SOU EXTENSION 4 GRANTED
Monday, March 25, 2024SOU TEAS EXTENSION RECEIVED
Monday, March 25, 2024SOU EXTENSION 4 FILED
Tuesday, March 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 7, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

trental circulatory disorders arteriovenous arterial preparations treatment pharmaceutical